RxDoctor Payments Data

Ashlyn Monaghan, PA

Physician Assistant · Dallas, TXNPI 1265917256

Payments from drug & device makers

$3,101in general payments, 2019–2025

Across 187 payments — averaging $16.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$568
  • Lilly USA, LLC$564
  • AbbVie$528
  • Pfizer$242
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$178
  • Merck$151
  • plus $872 from 17 others

What the payments were for

  • Food & beverage$3,100100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,101 in reported general payments places this provider in the 80th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$9,700
Medicare patients
33
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$32,148
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,613
Janumet XrSitagliptin Phos/Metformin Hcl12$6,919
Atorvastatin Calcium94$1,011
Gabapentin31$527
Lisinopril50$416
Levothyroxine Sodium36$394
Nebivolol Hcl11$388
Amlodipine Besylate44$343
Losartan Potassium42$326
Simvastatin17$293
Bupropion XlBupropion Hcl14$249
Omeprazole11$215
Chlorthalidone12$176
Pantoprazole Sodium20$145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$568$32,14818 claims
GSKTrelegy Ellipta$126$18,61321 claims
MerckJanumet Xr$151$6,91912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →